EP News Bureau

CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair

Read more

Bayer revises access model for Eylea 2mg in India to expand patient eligibility

Read more

Patent expiries ahead, is India Pharma Inc ready?

Read more

Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India

Read more

Lupin completes acquisition of VISUfarma

Read more

Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US

Read more

Agilent expands India’s scientific ecosystem with new customer experience centre in Mumbai

Read more

Express Pharma April 2026

Read more

Enthral.ai partners with Alembic Pharmaceuticals to deploy LMS platform

Read more

Eli Lilly to acquire Centessa Pharmaceuticals under definitive agreement

Read more